compounded semaglutide what is it for Women FDA alerts health care providers,
Description
Clinically proven for sustainable weight management
Discover GLP-1 weight loss drugs in India (2026)
Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptorsGLP-1, GIP, and glucagonpositioning it as a next-generation triple agonist. In research settings, it has been examined for its potential influence on appetite regulation, energy utilization, and body-weightrelated endpoints
They should only be used under the supervision of a qualified healthcare provider
Semaglutide (sold under the brand names Waygovy or Ozempic) is an FDA-approved weight loss medication that falls under the category of GLP-1 receptor agonists
Final Thoughts
